ArticleMolecular therapy. Methods & clinical development2023
Rationale for using centralized transduction inhibition assays in three phase 3 rAAV gene therapy clinical trials.
Martin Schulz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.